{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:50:03Z","timestamp":1791589803407,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The vascular norepinephrine response index [VNERi\u2009=\u2009diastolic arterial pressure \/ (norepinephrine dose \u00d7 heart rate)] is a bedside index computed from already-monitored signals. It has been studied only at baseline. We described its 48-hour course and tested whether it adds prognostic information beyond dynamic clinical measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We studied a single-center prospective cohort of 94 adults with septic shock started on first-line norepinephrine. VNERi was computed at hours T0\u2013T48. Course parameters (mean level, minimum, slope) were compared for 28-day mortality against the change in Sequential Organ Failure Assessment (SOFA) score (\u0394SOFA) and lactate clearance, using the area under the receiver operating characteristic curve (AUC) with the DeLong test, nested logistic regression, and time-dependent Cox regression adjusted for time-varying SOFA(t) and lactate(t). Phenotypes came from a latent class mixed model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Mortality was 32% (30\/94). Baseline VNERi did not separate outcomes (AUC 0.59; most had a preserved response). The course parameters did (mean-level AUC 0.73) but did not outperform \u0394SOFA (AUC 0.84, window-matched DeLong p\u2009=\u20090.02). Added to a dynamic clinical model, VNERi gave a small gain (integrated discrimination improvement 0.05\u20130.06, likelihood-ratio p\u2009\u2248\u20090.02). In time-dependent Cox, a higher VNERi(t) was linked to survival (hazard ratio 0.48) but weakened to non-significance after adjusting for SOFA(t) (0.68, p\u2009=\u20090.08). Three exploratory course phenotypes separated survival (log-rank p\u2009=\u20090.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Serial bedside VNERi monitoring is feasible and carries a partly independent signal that adds a small amount to dynamic clinical severity without outperforming it. These findings are hypothesis-generating and need validation in a hyporesponsive population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10877-026-01516-x","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:50:05Z","timestamp":1791543005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bedside monitoring of the vascular response to norepinephrine in early septic shock: VNERi trajectories and comparison with dynamic clinical measures"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-2187","authenticated-orcid":false,"given":"Yusuf","family":"Karanc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulya","family":"\u00c7iyiltepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Ak\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Beggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"1516_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"1516_CR2","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMra1208943","volume":"369","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726\u201334. https:\/\/doi.org\/10.1056\/NEJMra1208943.","journal-title":"N Engl J Med"},{"key":"1516_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0000000000007075","volume":"54","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, M\u00f8ller MH, Alshamsi F, Azevedo LCP, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026;54:725\u2013812. https:\/\/doi.org\/10.1097\/CCM.0000000000007075.","journal-title":"Crit Care Med"},{"key":"1516_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779\u201389. https:\/\/doi.org\/10.1056\/NEJMoa0907118.","journal-title":"N Engl J Med"},{"key":"1516_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jcrc.2018.10.032","volume":"51","author":"O Hamzaoui","year":"2019","unstructured":"Hamzaoui O, Teboul JL. Importance of diastolic arterial pressure in septic shock: PRO. J Crit Care. 2019;51:238\u201340. https:\/\/doi.org\/10.1016\/j.jcrc.2018.10.032.","journal-title":"J Crit Care"},{"key":"1516_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13613-020-00658-8","volume":"10","author":"GA Ospina-Tasc\u00f3n","year":"2020","unstructured":"Ospina-Tasc\u00f3n GA, Teboul JL, Hern\u00e1ndez G, Alvarez I, S\u00e1nchez-Ortiz AI, Calder\u00f3n-Tapia LE, et al. Diastolic shock index and clinical outcomes in patients with septic shock. Ann Intensive Care. 2020;10:41. https:\/\/doi.org\/10.1186\/s13613-020-00658-8.","journal-title":"Ann Intensive Care"},{"key":"1516_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-025-01454-y","volume":"15","author":"A Goury","year":"2025","unstructured":"Goury A, Djerada Z, Hern\u00e1ndez G, Kattan E, Griffon R, Ospina-Tasc\u00f3n G, et al. Ability of diastolic arterial pressure to better characterize the severity of septic shock when adjusted for heart rate and norepinephrine dose. Ann Intensive Care. 2025;15:43. https:\/\/doi.org\/10.1186\/s13613-025-01454-y.","journal-title":"Ann Intensive Care"},{"key":"1516_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13613-025-01520-5","volume":"15","author":"A Goury","year":"2025","unstructured":"Goury A, Djerada Z, Teboul JL, Hamzaoui O. Vascular hyporesponsiveness to norepinephrine is a major but not exclusive determinant of mortality in septic shock. Ann Intensive Care. 2025;15:96. https:\/\/doi.org\/10.1186\/s13613-025-01520-5.","journal-title":"Ann Intensive Care"},{"key":"1516_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Ospina-Tasc\u00f3n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654\u201364. https:\/\/doi.org\/10.1001\/jama.2019.0071.","journal-title":"JAMA"},{"key":"1516_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1164\/rccm.200912-1918OC","volume":"182","author":"TC Jansen","year":"2010","unstructured":"Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752\u201361. https:\/\/doi.org\/10.1164\/rccm.200912-1918OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1516_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00134-018-5213-x","volume":"45","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Bellomo R, Bakker J. The ten pitfalls of lactate clearance in sepsis. Intensive Care Med. 2019;45:82\u20135. https:\/\/doi.org\/10.1007\/s00134-018-5213-x.","journal-title":"Intensive Care Med"},{"key":"1516_CR12","doi-asserted-by":"publisher","first-page":"R278","DOI":"10.1186\/cc13133","volume":"17","author":"M Legrand","year":"2013","unstructured":"Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care. 2013;17:R278. https:\/\/doi.org\/10.1186\/cc13133.","journal-title":"Crit Care"},{"key":"1516_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"key":"1516_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55\u201363. https:\/\/doi.org\/10.7326\/M14-0697.","journal-title":"Ann Intern Med"},{"key":"1516_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","volume":"27","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated norepinephrine equivalent score in intensive care as a marker of shock severity. Crit Care. 2023;27:29. https:\/\/doi.org\/10.1186\/s13054-023-04322-y.","journal-title":"Crit Care"},{"key":"1516_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. Intensive Care Med. 1996;22:707\u201310. https:\/\/doi.org\/10.1007\/BF01709751.","journal-title":"Intensive Care Med"},{"key":"1516_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204. https:\/\/doi.org\/10.1186\/cc11454.","journal-title":"Crit Care"},{"key":"1516_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345. https:\/\/doi.org\/10.2307\/2531595.","journal-title":"Biometrics"},{"key":"1516_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB, Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u201372. . https:\/\/doi.org\/10.1002\/sim.2929","journal-title":"Stat Med"},{"key":"1516_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v078.i02","volume":"78","author":"C Proust-Lima","year":"2017","unstructured":"Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017;78:1\u201356. https:\/\/doi.org\/10.18637\/jss.v078.i02.","journal-title":"J Stat Softw"},{"key":"1516_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the Cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000. https:\/\/doi.org\/10.1007\/978-1-4757-3294-8."},{"key":"1516_CR22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317. https:\/\/doi.org\/10.1001\/jama.2019.5791.","journal-title":"JAMA"},{"key":"1516_CR23","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s00134-022-06890-z","volume":"48","author":"SV Bhavani","year":"2022","unstructured":"Bhavani SV, Semler M, Qian ET, Verhoef PA, Robichaux C, Churpek MM, et al. Development and validation of novel sepsis subphenotypes using trajectories of vital signs. Intensive Care Med. 2022;48:1582\u201392. https:\/\/doi.org\/10.1007\/s00134-022-06890-z.","journal-title":"Intensive Care Med"},{"key":"1516_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877\u201387. https:\/\/doi.org\/10.1056\/NEJMoa067373.","journal-title":"N Engl J Med"},{"key":"1516_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1704154.","journal-title":"N Engl J Med"},{"key":"1516_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1705716.","journal-title":"N Engl J Med"},{"key":"1516_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378:797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835.","journal-title":"N Engl J Med"},{"key":"1516_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","volume":"199","author":"C Permpikul","year":"2019","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized controlled trial. Am J Respir Crit Care Med. 2019;199:1097\u2013105. https:\/\/doi.org\/10.1164\/rccm.201806-1034OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1516_CR29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: the 65 randomized clinical trial. JAMA. 2020;323:938\u201349. https:\/\/doi.org\/10.1001\/jama.2020.0930.","journal-title":"JAMA"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-026-01516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-026-01516-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-026-01516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:02:08Z","timestamp":1791586928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-026-01516-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":29,"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1007\/s10877-026-01516-x","relation":{},"ISSN":["1573-2614"],"issn-type":[{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"9 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Scientific Ethics Committee for Medical Research of Antalya Training and Research Hospital (decision no 20\/13, date 27 November 2025).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients included in the study or from their legal representatives.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study registration This observational cohort study was not registered in a clinical trialregistry. The study protocol was submitted to and approved by the institutional ethics committee before data collection began, but it was not published ordeposited in a public repository. The primary hypothesis, the primary outcome, the eligibility criteria, and the measurement time points were defined apriori in that protocol, and the renal variables were collected prospectively under it. The study departed from the protocol in three ways, which we reportfor transparency. The protocol planned a multicenter cohort of about 200 patients, whereas the study as conducted was single-center and enrolled 94. Themeasurement schedule was changed, in that the hour 1 and hour 2 time points were not used, and renal variables were recorded daily for 7 days rather thanonly within the first 48 hours. The other secondary endpoints and secondary hypotheses in the protocol, which concerned vasopressor-free, renal-replacement-free and ventilator-free days, the response to alternative vasopressors, and successful vasopressor weaning, are not reported in this analysis.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used a generative AI tool only for grammar and spelling corrections. The authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":5,"name":"Ethics","label":"Declaration of generative AI in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}